Plantar FasciitisNCT07463794
Comparison of Extracorporeal Shock Wave Therapy and Whole Body Vibration Therapy in Plantar Fasciitis
A study testing Extracorporeal Shock Wave Therapy and Whole Body Vibration Therapy in people with Plantar Fasciitis and Calcaneal Spur, run by Gaziosmanpasa Research and Education Hospital at 1 site in Turkey (Türkiye).
Trial summary
Plantar fasciitis is a common cause of heel pain that can lead to functional limitation and decreased quality of life. Various conservative treatment modalities are used in its management. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Plantar Fasciitis, Calcaneal Spur
- What is being tested?
- Extracorporeal Shock Wave Therapy and Whole Body Vibration Therapy
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Aug 2025to 20 Mar 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age between 18 and 65 years
- Clinically diagnosed plantar fasciitis
- Heel pain lasting at least 4 weeks
- Ability to understand the study procedures and provide written informed consent
Who cannot join
- History of inflammatory rheumatic diseases
- Previous foot or ankle surgery
- Major trauma to the foot or ankle
- Neurological or vascular disorders of the lower extremities
- Pregnancy or lactation
- Corticosteroid injection to the foot within the last 3 months
- Physical therapy, extracorporeal shock wave therapy, or whole body vibration therapy within the last 3 months
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Gaziosmanpaşa Training and Research Hospital
Istanbul, 34245
About this study
Official title: Plantar Fasiit Tedavisinde ESWT ve Tüm Vücut Vibrasyon Uygulamalarının Etkinliğinin Karşılaştırılması: Randomize, Prospektif, Tek Kör Çalışma
Plantar fasciitis is a common cause of heel pain that can lead to functional limitation and decreased quality of life. Various conservative treatment modalities are used in its management. This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and whole body vibration therapy in patients with plantar fasciitis. The study is designed as a randomized, prospective, single-blind clinical trial. Clinical outcomes will be evaluated using pain and functional assessment scales before and after treatment.
Read the detailed description
This randomized, prospective, single-blind clinical trial was conducted to compare the effects of extracorporeal shock wave therapy (ESWT) and whole body vibration therapy in patients diagnosed with plantar fasciitis. A total of 60 patients aged between 18 and 65 years were included in the final analysis. Participants were randomly assigned into two groups.
The first group received extracorporeal shock wave therapy applied once weekly for a total of five sessions. The second group received whole body vibration therapy three times per week for five weeks. Both groups followed the same standardized home exercise program during the treatment period.
Clinical evaluations were performed at baseline, at the end of treatment, and at the ninth week. The primary outcome measure was functional status assessed using the Foot Function Index (FFI). Secondary outcome measures included pain intensity assessed by the Visual Analog Scale (VAS), the American Orthopaedic Foot and Ankle Society (AOFAS) score, and the Roles and Maudsley score.The aim of this study is to determine and compare the clinical effectiveness of ESWT and whole body vibration therapy in the management of plantar fasciitis.
- Conditions
- Plantar Fasciitis, Calcaneal Spur
- Being tested
- Extracorporeal Shock Wave Therapy, Whole Body Vibration Therapy
- Keywords
- Plantar Fasciitis, Extracorporeal Shock Wave Therapy, ESWT, Whole Body Vibration Therapy, Foot Function Index, Randomized Controlled Trial
- Medical subject headings
- Fasciitis, Plantar, Heel Spur
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Extracorporeal Shock Wave TherapyDevice
Extracorporeal shock wave therapy was applied once weekly for a total of five sessions to the affected heel.
Whole Body Vibration TherapyDevice
Whole body vibration therapy was applied three times per week for five weeks using a vibration platform.
| Study group | Role | What they receive |
|---|---|---|
| Extracorporeal Shock Wave Therapy (ESWT) | Experimental | Participants received extracorporeal shock wave therapy once weekly for five sessions. Receives: Device: Extracorporeal Shock Wave Therapy |
| Whole Body Vibration Therapy | Experimental | Participants received whole body vibration therapy three times per week for five weeks. Receives: Device: Whole Body Vibration Therapy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Foot Function Index (FFI)
Foot Function Index (FFI), a self-reported questionnaire consisting of 23 items in three subscales (pain, disability, and activity limitation), with scores ranging from 0 to 100. Higher scores indicate worse foot-related disability.
Measured: Baseline, 5 weeks and 9 weeks
Secondary outcomes (3)
Visual Analog Scale (VAS)
Pain severity assessed using the Visual Analog Scale (VAS).Visual Analog Scale (VAS) for pain, ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse pain.
Measured: Baseline, 5 weeks and 9 weeks
American Orthopaedic Foot and Ankle Society Score (AOFAS)
American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score, ranging from 0 to 100, where higher scores indicate better function.
Measured: Baseline, 5 weeks and 9 weeks
Roles and Maudsley Score
Clinical outcome assessed using the Roles and Maudsley score.Roles and Maudsley Score (RM score), a 4-point ordinal scale ranging from 1 (excellent) to 4 (poor). Lower scores indicate better clinical outcome.
Measured: Baseline, 5 weeks and 9 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Mar 2026
- Study start1 Aug 2025
- Primary completion20 Mar 2026
- Study completion20 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Plantar FasciitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants were randomly assigned to one of two parallel groups to receive either extracorporeal shock wave therapy or whole body vibration therapy.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Gaziosmanpasa Research and Education Hospital
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- Berrin Hüner, Principal investigator, Gaziosmanpaşa Training and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07463794
- Sponsor's protocol ID
- IMU-EC-945-2025
- Status last verified
- Feb 2026
- First submitted
- 30 Jan 2026
- Last updated
- 10 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared because the study is a single-center academic thesis study, and the data contain personal and sensitive health information. There is no separate data-sharing agreement or repository planned for this study.
Publications
Gerdesmeyer L, Frey C, Vester J, et al. Radial extracorporeal shock wave therapy is safe and effective in the treatment of chronic plantar fasciitis. Journal of Rehabilitation Medicine. 2008;40(6):425-430. doi:10.2340/jrm.v55.12405.
Study at a glance
From the registry record, last updated by the sponsor on 10 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Plantar Fasiit Tedavisinde ESWT ve Tüm Vücut Vibrasyon Uygulamalarının Etkinliğinin Karşılaştırılması: Randomize, Prospektif, Tek Kör Çalışma
- ClinicalTrials.gov ID
- NCT07463794
- Acronym / sponsor ID
- IMU-EC-945-2025
- Conditions
- Plantar Fasciitis, Calcaneal Spur
- Keywords
- Plantar Fasciitis, Extracorporeal Shock Wave Therapy, ESWT, Whole Body Vibration Therapy, Foot Function Index, Randomized Controlled Trial
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Gaziosmanpasa Research and Education HospitalOther government
- Study start
- 1 Aug 2025 (actual)
- Primary completion
- 20 Mar 2026 (actual)
- Study completion
- 20 Mar 2026 (actual)
- First posted
- 11 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Plantar fasciitis is a common cause of heel pain that can lead to functional limitation and decreased quality of life. Various conservative treatment modalities are used in its management. This study aims to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and whole body vibration therapy in patients with plantar fasciitis. The study is designed as a randomized, prospective, single-blind clinical trial. Clinical outcomes will be evaluated using pain and functional assessment scales before and after treatment.
Detailed description
This randomized, prospective, single-blind clinical trial was conducted to compare the effects of extracorporeal shock wave therapy (ESWT) and whole body vibration therapy in patients diagnosed with plantar fasciitis. A total of 60 patients aged between 18 and 65 years were included in the final analysis. Participants were randomly assigned into two groups.
The first group received extracorporeal shock wave therapy applied once weekly for a total of five sessions. The second group received whole body vibration therapy three times per week for five weeks. Both groups followed the same standardized home exercise program during the treatment period.
Clinical evaluations were performed at baseline, at the end of treatment, and at the ninth week. The primary outcome measure was functional status assessed using the Foot Function Index (FFI). Secondary outcome measures included pain intensity assessed by the Visual Analog Scale (VAS), the American Orthopaedic Foot and Ankle Society (AOFAS) score, and the Roles and Maudsley score.The aim of this study is to determine and compare the clinical effectiveness of ESWT and whole body vibration therapy in the management of plantar fasciitis.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Participants were randomly assigned to one of two parallel groups to receive either extracorporeal shock wave therapy or whole body vibration therapy.
| Arm | Type | Receives |
|---|---|---|
| Extracorporeal Shock Wave Therapy (ESWT) | Experimental | Device: Extracorporeal Shock Wave TherapyParticipants received extracorporeal shock wave therapy once weekly for five sessions. |
| Whole Body Vibration Therapy | Experimental | Device: Whole Body Vibration TherapyParticipants received whole body vibration therapy three times per week for five weeks. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Age between 18 and 65 years
- Clinically diagnosed plantar fasciitis
- Heel pain lasting at least 4 weeks
- Ability to understand the study procedures and provide written informed consent
Key exclusion criteria (7 listed)
- History of inflammatory rheumatic diseases
- Previous foot or ankle surgery
- Major trauma to the foot or ankle
- Neurological or vascular disorders of the lower extremities
- Pregnancy or lactation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Extracorporeal Shock Wave TherapyExtracorporeal shock wave therapy was applied once weekly for a total of five sessions to the affected heel. | Device | Extracorporeal Shock Wave Therapy (ESWT) |
| Whole Body Vibration TherapyWhole body vibration therapy was applied three times per week for five weeks using a vibration platform. | Device | Whole Body Vibration Therapy |
Primary outcome
Foot Function Index (FFI)
Time frame: Baseline, 5 weeks and 9 weeks
Foot Function Index (FFI), a self-reported questionnaire consisting of 23 items in three subscales (pain, disability, and activity limitation), with scores ranging from 0 to 100. Higher scores indicate worse foot-related disability.
3 secondary outcomes
Visual Analog Scale (VAS)
Time frame: Baseline, 5 weeks and 9 weeks
American Orthopaedic Foot and Ankle Society Score (AOFAS)
Time frame: Baseline, 5 weeks and 9 weeks
Roles and Maudsley Score
Time frame: Baseline, 5 weeks and 9 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Jun 2026.
- BackgroundGerdesmeyer L, Frey C, Vester J, et al. Radial extracorporeal shock wave therapy is safe and effective in the treatment of chronic plantar fasciitis. Journal of Rehabilitation Medicine. 2008;40(6):425-430. doi:10.2340/jrm.v55.12405.
- Individual participant dataSharing planned: No. Individual participant data will not be shared because the study is a single-center academic thesis study, and the data contain personal and sensitive health information. There is no separate data-sharing agreement or repository planned for this study.
Related trials for Plantar Fasciitis
Not yet recruiting
Efficacy of TECAR Therapy in Plantar Fasciitis
Plantar Fasciitis
Not yet recruiting
Radial vs Focused Shockwave Therapy for Plantar Fasciitis
Plantar Fasciitis, Chronic
RecruitingObservational study
Tibial Nerve Size and Clinical Features in Chronic Plantar Fasciitis
Plantar Fasciitis, Chronic, Tibial Nerve
Recruiting
Video-Based Versus Physician-Led Exercise Training for Plantar Fasciitis
Plantar Fasciitis of Both Feet, Plantar Fascitis
Recruiting
Extracorporeal Shock Wave Therapy With or Without Kinesiotaping for Plantar Fasciitis
Plantar Fasciitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Berrin Hüner principal investigator
Gaziosmanpaşa Training and Research Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Extracorporeal Shock Wave Therapy and Whole Body Vibration Therapy in people with Plantar Fasciitis and Calcaneal Spur, run by Gaziosmanpasa Research and Education Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Foot Function Index (FFI) (time frame: Baseline, 5 weeks and 9 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07463794, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2026; AzTrials last refreshed its copy on 7 Nov 2026.